molindone has been researched along with Drug Withdrawal Symptoms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, DY; Lindenmayer, JP | 1 |
| Glazer, WM | 1 |
| Benarroche, CL; Glazer, WM; Hafez, HM | 1 |
1 review(s) available for molindone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Humans; Incidence; Molindone; Olanzapine; Pirenzepine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis | 2000 |
2 trial(s) available for molindone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Humans; Incidence; Molindone; Olanzapine; Pirenzepine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis | 2000 |
Molindone and haloperidol in tardive dyskinesia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Indoles; Male; Middle Aged; Molindone; Psychotic Disorders; Receptors, Dopamine; Schizophrenia; Substance Withdrawal Syndrome | 1985 |
1 other study(ies) available for molindone and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Aripiprazole-induced agitation after clozapine discontinuation: a case report.
Topics: Akathisia, Drug-Induced; Alcoholism; Antipsychotic Agents; Aripiprazole; Clozapine; Cocaine-Related Disorders; Comorbidity; Delayed-Action Preparations; Diabetic Ketoacidosis; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Middle Aged; Molindone; Piperazines; Quinolones; Schizophrenia, Paranoid; Substance Withdrawal Syndrome | 2009 |